Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp is a rare condition that causes scarring hair loss, mainly in older women, and requires ongoing treatment.

Ex vivo dermatoscopy may lower lab costs and improve diagnosis speed for hair loss biopsies.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Hair transplantation effectively treats scalp scars with high success and patient satisfaction.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

New scalp surgery technique results in thinner, less visible scars.

Both ASR I and ASR II are effective scalp reduction techniques, with ASR I creating finer scars and ASR II removing more bald area and reducing stretch-back.

The conclusion is that closing scalp wounds is possible, but restoring hair without donor material is still a major challenge.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

A new scalp surgery technique leads to significantly thinner scars.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Scalp diseases change with age and can be hard to tell apart from hair disorders.

Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

High-frequency ultrasound can effectively visualize and assess hair loss.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

The new Follicular Map method could help assess hair treatment effectiveness but has some limitations.

Unsatisfactory hair restoration results can be significantly improved with strategic hair redistribution and new donor hair placement, despite previous surgery challenges.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.